Substance

ID:348334

Names and Identifiers
IUPAC Traditional name
adefovir dipivoxil
IUPAC name
[({[2-(6-amino-9H-purin-9-yl)ethoxy]methyl}({[(2,2-dimethylpropanoyl)oxy]methoxy})phosphoryl)oxy]methyl 2,2-dimethylpropanoate
Synonyms
9-(2[bis(Pivaloyloxymethoxy)phosphorylmethoxy]ethyl)adenineAdefovir dipivoxil
Registration numbers
CAS Number
MDL Number
Properties
Safety Information
Safety Statements
36/37
GHS Hazard statements
H302-H312-H332
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Storage Temperature
-20°C
MSDS Link
GHS Signal Word
Warning
GHS Precautionary statements
P280
Risk Statements
20/21/22
German water hazard class
3
GHS Pictograms
GHS07
Acute toxicity (oral, dermal, inhalation), category 4
Skin irritation, category 2
Eye irritation, category 2
Skin sensitisation, category 1
Specific Target Organ Toxicity – Single exposure, category 3
European Hazard Symbols
Harmful Harmful (Xn)
Product Information
Empirical Formula (Hill Notation)
C20H32N5O8P
Molecule Details
Biochem/physiol Actions
Antiviral acyclic nucleoside phosphonate (ANP) analog.
Adefovir is an antiviral acyclic nucleoside phosphonate (ANP) analog.that works by blocking reverse transcriptase 3. It is an inhibitor of duck hepatitis B virus (DHBV) replication that inhibits covalently closed circular DNA (CCC DNA) amplification 4. Cytotxicity is induced by Human Renal Organic Anion Transporter 1 (hOAT1) 5. Adefovir is an Inhibitor of edema factor (EF)-induced cAMP accumulation and changes in cytokine production in mouse primary macrophages 2.
Application
Adefovir is used to treat hepatitis B infections. It is used to study organ-specific toxicity and immune mechanisms of Adefovir treatment 1,2.
Molecular Spectra
No Data Available
Click here to submit data
References
No Data Available
Click here to submit data